Detalhe da pesquisa
1.
Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model.
J Immunol
; 211(9): 1426-1437, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37712758
2.
The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Transpl Infect Dis
; 26(2): e14241, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38269469
3.
Clofarabine Preconditioning followed by Allogeneic Transplant Using TBI and Post-Transplant Cyclophosphamide for Relapsed Refractory Leukemia.
Int J Mol Sci
; 25(2)2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38256031
4.
Donor HLA mismatch promotes full donor T-cell chimerism in the allogeneic stem cell transplant with reduced-intensity conditioning and post-transplant cyclophosphamide GVHD prophylaxis.
Ann Hematol
; 102(3): 613-620, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36527460
5.
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma.
N Engl J Med
; 378(1): 35-47, 2018 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298160
6.
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Blood
; 133(7): 754-762, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545834
7.
Improved outcome in AML relapse after allogeneic transplant with high-intensity chemotherapy followed by 2nd allogeneic stem cell transplant or donor lymphocyte infusion.
Ann Hematol
; 100(10): 2585-2592, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322774
8.
[The coronavirus disease 2019 (COVID-19) and hematologic oncology or BMT practice at our center in US].
Rinsho Ketsueki
; 62(8): 998-1003, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34497240
9.
Multi-dimensional analysis identifies an immune signature predicting response to decitabine treatment in elderly patients with AML.
Br J Haematol
; 188(5): 674-684, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31573077
10.
[Transplant conditioning revisited].
Rinsho Ketsueki
; 61(9): 1411-1416, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-33162543
11.
Association of Antiepileptic Medications with Outcomes after Allogeneic Hematopoietic Cell Transplantation with Busulfan/Cyclophosphamide Conditioning.
Biol Blood Marrow Transplant
; 25(7): 1424-1431, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871976
12.
Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2398-2407, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473319
13.
Effect of Conditioning Regimen Dose Reduction in Obese Patients Undergoing Autologous Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(3): 480-487, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423481
14.
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
Blood
; 130(2): 221-228, 2017 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468799
15.
Programming of donor T cells using allogeneic δ-like ligand 4-positive dendritic cells to reduce GVHD in mice.
Blood
; 127(25): 3270-80, 2016 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-27143255
16.
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure.
Blood
; 127(13): 1656-65, 2016 Mar 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26825712
17.
The Notch Ligand DLL4 Defines a Capability of Human Dendritic Cells in Regulating Th1 and Th17 Differentiation.
J Immunol
; 196(3): 1070-80, 2016 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712946
18.
Hematopoietic stem cell transplantation in the era of molecular targeted therapy.
Rinsho Ketsueki
; 58(10): 2135-2140, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28978858
19.
Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies.
Biol Blood Marrow Transplant
; 22(8): 1424-1430, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27154848
20.
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.
Biol Blood Marrow Transplant
; 22(4): 594-604, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26806585